TABLE 1.
Oligonucleotide | Kd (nM)e | DNA binding specificityf | Binding site sequenceg |
---|---|---|---|
Wild type | 2.3 | 1.0 | GATTCTGTTTTAACAGCTTT |
−422 mutation | >240 | <0.010 | GATTCTGTTTTAACAGATTT |
−425 mutation | >100 | <0.023 | GATTCTGTTTTAAAAGCTTT |
Clustered mutationsa | >140 | <0.016 | CATTATCTTTAAAGAACTTT |
−435 mutation | 12.4 | 0.185 | GATGCTGTTTTAACAGCTTT |
−433 mutation | 38 | 0.061 | GATTCGGTTTTAACAGCTTT |
V-(D)-J signalb | 32 | 0.072 | GATCCCACAGTGCTCCAGGGCTGAACAAAAACCGAATT |
GATAc | >500 | <0.005 | GGGCAACTGATAAGGATTCC |
MAD 7,8d | >500 | <0.005 | GAAACTAAGGTACAGAAGTT |
This oligonucleotide contains a cluster of six point mutations within PRE II (51).
T160, the murine ortholog of SSRP1, was isolated from a cDNA expression library by using an oligonucleotide containing a murine V-(D)-J RSS (40).
GATA binding site of the mouse α1-globin promoter (52).
An irrelevant DNA sequence upstream of the PRE II DNA recognition element of the ɛ-globin gene (50).
Individual point mutations were characterized previously for PREIIBF binding (15). A subset of these was used to calculate Kds for rSSRP1.
Defined as the ratio of the wild-type Kd to test sequence Kd.
Mutated nucleotides are underlined.